GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Pleiades Publishing Ltd ; 2022
    In:  Journal of Evolutionary Biochemistry and Physiology Vol. 58, No. 6 ( 2022-11), p. 2007-2020
    In: Journal of Evolutionary Biochemistry and Physiology, Pleiades Publishing Ltd, Vol. 58, No. 6 ( 2022-11), p. 2007-2020
    Type of Medium: Online Resource
    ISSN: 0022-0930 , 1608-3202
    Language: English
    Publisher: Pleiades Publishing Ltd
    Publication Date: 2022
    detail.hit.zdb_id: 2031099-7
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Pleiades Publishing Ltd ; 2023
    In:  Journal of Evolutionary Biochemistry and Physiology Vol. 59, No. 1 ( 2023-01), p. 107-118
    In: Journal of Evolutionary Biochemistry and Physiology, Pleiades Publishing Ltd, Vol. 59, No. 1 ( 2023-01), p. 107-118
    Type of Medium: Online Resource
    ISSN: 0022-0930 , 1608-3202
    Language: English
    Publisher: Pleiades Publishing Ltd
    Publication Date: 2023
    detail.hit.zdb_id: 2031099-7
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Advances in Molecular Oncology, Publishing House ABV Press, Vol. 9, No. 2 ( 2022-06-26), p. 89-96
    Abstract: Introduction. In the structure of cancer incidence, lung cancer ranks first among men. In order to study the molecular mechanisms of the initiation and progression of lung cancer, it is necessary to study not only the tumor cells themselves, but also the features of the systemic tryptophan metabolism. Tryptophan catabolites, being to a large extent product of the metabolic activity of the intestinal microbiota, can affect the effectiveness of immunotherapy with checkpoint inhibitors. The kynurenine pathway of tryptophan metabolism is intensified in the body of cancer patients; its products have a pro-oncogenic and immunosuppressive effect, which may hinder the effectiveness of immunotherapy. Objective – to study the dynamics of changes in various metabolites of tryptophan metabolism in the blood serum and feces of patients with non-small cell lung cancer with various effects of immunotherapy with inhibitors of PD-1 (programmed cell death receptor 1) / PD-L1 (programmed cell death receptor 1 ligand). Materials and methods. The study included blood serum and stool samples obtained from 20 patients with non-small cell lung cancer treated with PD-1 / PD-L1 inhibitors. Using high-performance liquid chromatography with mass spectrometric analysis, the levels of 13 tryptophan metabolites were assessed in patients with various effects of immunotherapy. The significance of differences between the samples was assessed using a nonparametric method according to the Mann – Whitney test. They were considered statistically significant at p 〈 0.05. Results. In fecal analyzes of patients in whom a positive effect of immunotherapy was observed, baseline levels of 5-hydroxyindole acetate and quinolinic acid were lower than in patients with tumor progression. Positive clinical dynamics was accompanied by a decrease in the content of indole-3-lactate, kynurenine and indole-3-carboxaldehyde in the feces of patients. In the serum of patients with a positive response, the initial content of 5-hydroxyindole acetate, indole-3-acetate, indole-3-butyrate and quinoline acid was lower than in patients with progression of non-small cell lung cancer. A positive response to immunotherapy was characterized by an increase in the levels of indole-3-butyrate and indole-3-propionate, and a negative response was not accompanied by statistically significant changes in the studied tryptophan metabolites. Conclusion. Profiling tryptophan metabolites in feces and serum of patients with non-small cell lung cancer can be used to predict the effectiveness of immunotherapy with PD-1 / PD-L1 inhibitors.
    Type of Medium: Online Resource
    ISSN: 2413-3787 , 2313-805X
    URL: Issue
    Language: Unknown
    Publisher: Publishing House ABV Press
    Publication Date: 2022
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Siberian State Medical University ; 2022
    In:  Bulletin of Siberian Medicine Vol. 20, No. 4 ( 2022-01-03), p. 103-111
    In: Bulletin of Siberian Medicine, Siberian State Medical University, Vol. 20, No. 4 ( 2022-01-03), p. 103-111
    Abstract: Aim . To assess the concentrations of bacterial and eukaryotic metabolites mainly involved in indole, kynurenine, and serotonin pathways of tryptophan metabolism in a cohort of patients with obesity. Materials and methods. Using high-performance liquid chromatography with mass spectrometric detection, the concentrations of several serum metabolites, such as kynurenine, kynurenic acid, anthranilic acid, xanthurenic acid, quinolinic acid, 5-hydroxyindole-3-acetate, tryptamine, serotonin, indole-3-lactate, indole-3-acetate, indole-3- butyrate, indole-3-carboxaldehyde, indole-3-acrylate, and indole-3-propionate, were analyzed in a cohort of obese patients compared with healthy volunteers. Results . It was found that serum levels of tryptophan metabolites of microbial and eukaryotic origin were significantly increased in obese patients. Therefore, the concentration of kynurenine in the blood serum in obese patients was 2,413 ± 855 nmol / l, while in healthy volunteers of the same age group, the level of kynurenine in the blood serum was 2,122 ± 863 nmol / l. In obese patients, two acids formed due to kynurenine metabolism; the concentrations of kynurenic and quinolinic acids were increased in the blood serum. The concentration of kynurenic acid in the blood serum in obese patients was 21.1 ± 9.26 nmol / l, and in healthy patients, it was 16.8 ± 8.37 nmol / l. At the same time, the level of quinolinic acid in the blood serum in obese patients was 73.1 ± 54.4 nmol / l and in healthy volunteers – 56.8 ± 34.1 nmol / l. Normally, the level of quinolinic acid is 3.4 times higher than the concentration of kynurenic acid, and in case of obesity, there is a comparable increase in these acids in the blood serum. From indole derivatives, mainly of microbial origin, the concentrations of indole-3-lactate, indole-3-butyrate, and indole-3-acetate were significantly increased in the blood serum of obese patients. In obese patients, the serum concentration of 5-hydroxyindole-3-acetate was elevated to 74.6 ± 75.8 nmol / l (in healthy volunteers – 59.4 ± 36.6 nmol / l); indole-3-lactate – to 523 ± 251 nmol / l (in healthy volunteers – 433 ± 208 nmol / l); indole-3-acetate – to 1,633 ± 1,166 nmol / l (in healthy volunteers – 1,186 ± 826 nmol / l); and indole-3-butyrate – to 4.61 ± 3.31 nmol / l (in healthy volunteers – 3.85 ± 2.51 nmol / l). Conclusion . In case of obesity, the utilization of tryptophan was intensified by both the microbiota population and the macroorganism. It was found that obese patients had higher concentrations of kynurenine, quinolinic and kynurenic acids, indole-3-acetate, indole-3-lactate, indole-3-butyrate, and 5-hydroxyindole-3-acetate. Apparently, against the background of increased production of proinflammatory cytokines by adipocytes in obese patients, the “kynurenine switch” was activated which contributed to subsequent overproduction of tryptophan metabolites involved in the immune function of the macroorganism. 
    Type of Medium: Online Resource
    ISSN: 1819-3684 , 1682-0363
    URL: Issue
    Language: Unknown
    Publisher: Siberian State Medical University
    Publication Date: 2022
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    ECO-Vector LLC ; 2017
    In:  Traumatology and Orthopedics of Russia Vol. 23, No. 4 ( 2017-12-26), p. 78-82
    In: Traumatology and Orthopedics of Russia, ECO-Vector LLC, Vol. 23, No. 4 ( 2017-12-26), p. 78-82
    Abstract: Introduction. Techniques that use growth factors to improve bone fragment consolidation and to treat the inflammatory and degenerative diseases of the musculoskeletal system have become very popular. Many researchers are actively searching for personification of this therapy and the reasons for delayed consolidation. The purpose of the study – to identify the biomarker for delayed bone consolidation.Materials and Methods. The study groups consisted of patients with high-energy tibia open fractures with normal (group 1) and with delayed (2nd group) consolidation of bone fragments. The enzymatic activity of platelet-derived growth factor (PDGF) in blood serum was studied after 7 days and in 1, 3 and 6 months after bone fragments reduction. Spectrophotometric technique (Specord-200) was used.Results. In patients with normal consolidation of bone fragments, the enzymatic activity of PDGF was statistically significantly higher in comparison with the group with delayed healing. At the same time, the highest activity was reported on day 7, and by third month it was becoming lower.Conclusion. Bone healing depends on PDGF enzymatic activity, besides significant differences on various stages of healing were observed. Further study the reasons for the PDGF enzymatic deficiency and its correction are of a great interest for reducing the timing of consolidation.
    Type of Medium: Online Resource
    ISSN: 2542-0933 , 2311-2905
    URL: Issue
    Language: Unknown
    Publisher: ECO-Vector LLC
    Publication Date: 2017
    detail.hit.zdb_id: 3070168-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Pleiades Publishing Ltd ; 2023
    In:  Journal of Evolutionary Biochemistry and Physiology Vol. 59, No. 4 ( 2023-07), p. 1360-1373
    In: Journal of Evolutionary Biochemistry and Physiology, Pleiades Publishing Ltd, Vol. 59, No. 4 ( 2023-07), p. 1360-1373
    Type of Medium: Online Resource
    ISSN: 0022-0930 , 1608-3202
    Language: English
    Publisher: Pleiades Publishing Ltd
    Publication Date: 2023
    detail.hit.zdb_id: 2031099-7
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    Pleiades Publishing Ltd ; 2023
    In:  Biology Bulletin Reviews Vol. 13, No. 2 ( 2023-04), p. 81-91
    In: Biology Bulletin Reviews, Pleiades Publishing Ltd, Vol. 13, No. 2 ( 2023-04), p. 81-91
    Type of Medium: Online Resource
    ISSN: 2079-0864 , 2079-0872
    Language: English
    Publisher: Pleiades Publishing Ltd
    Publication Date: 2023
    detail.hit.zdb_id: 2595495-7
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    Russian Society of Clinical Oncology ; 2017
    In:  Malignant tumours , No. 2 ( 2017-01-01), p. 83-89
    In: Malignant tumours, Russian Society of Clinical Oncology, , No. 2 ( 2017-01-01), p. 83-89
    Type of Medium: Online Resource
    ISSN: 2224-5057
    URL: Issue
    Language: Unknown
    Publisher: Russian Society of Clinical Oncology
    Publication Date: 2017
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    RIOR Publishing Center ; 2020
    In:  Crimea Journal of Experimental and Clinical Medicine Vol. 10, No. 2 ( 2020), p. 95-103
    In: Crimea Journal of Experimental and Clinical Medicine, RIOR Publishing Center, Vol. 10, No. 2 ( 2020), p. 95-103
    Abstract: Today, it is believed that the human body and the intestinal microbiota exist in a metabolic coupling based on the principle of mutualism. The main metabolic function of the intestinal microbiotic population is the hyperproduction of short-chain fatty acids, which perform an energy function for both microorganisms and human cells, regulate the quo- rum and participate in the response of immune cells of the macroorganism through specific signaling mechanisms. Also, a characteristic link in the metabolic coupling of the «superorganism» is the metabolic pathways of tryptophan and, respectively, indoles, kynurenines and serotonin. Indole acts as an interspecific signaling molecule and is respon- sible for both the bacterial quorum and, for example, regulates the differentiation of nerve tissue. Many metabolic path- ways of tryptophan conversion are amplified by the microbiotic community, but the formation of kynurenic acid, which is a signal molecule in energy metabolism, is characteristic only for the macroorganism. It should be noted the role of membrane bacterial vesicles in the interaction of the host and the microbiota as carriers of virulence factors and other modulators of the function of macroorganism cells. Despite a significant amount of research, the metabolic coupling of the «macroorganism – gut microbiota» system remains poorly understood. In this regard, the purpose of this review was to highlight some aspects of the metabolic interaction of the macroorganism and its microbiota.
    Type of Medium: Online Resource
    ISSN: 2224-6452 , 2224-6444
    Uniform Title: ОСОБЕННОСТИ МЕТАБОЛИЧЕСКОГО СОПРЯЖЕНИЯ В СИСТЕМЕ «СУПЕРОРГАНИЗМА» (ХОЗЯИН – МИКРОБИОТА)
    URL: Issue
    Language: Russian
    Publisher: RIOR Publishing Center
    Publication Date: 2020
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: Crimea Journal of Experimental and Clinical Medicine, RIOR Publishing Center, Vol. 11, No. 1 ( 2022), p. 16-24
    Abstract: In the last 10 years, there has been an active study of the system of coupling the metabolism of a macroorgan- ism and its microbiome. The microbiotic conversion of food substrates into small biologically active signaling mol- ecules represents a potential regulatory mechanism by which the gut microbiota can alter the physiology of gut cells and the entire macroorganism. It was found that in patients with obesity, but without metabolic disorders, the level of serum tryptamine was statistically significantly higher than in patients with metabolically unhealthy obesity. For obesity, regardless of the presence/absence of metabolic disorders, it was found that xanthurenic and quinolic acids stimulate the secretion of myostatin. At the same time, for patients with metabolically healthy obesity, the leading role of indole-3-acetate in the coordinated stimulation of insulin and leptin secretion is shown. Whereas in patients with metabolically unhealthy obesity, anthranilic acid stimulates leptin secretion. For insulin, the decrease in secretion is provided by indole-3-propionate in patients with metabolically unhealthy obesity. In addition, indole-3-propionate and tryptamine activate the secretion of FGF 21 in patients with metabolically unhealthy obesity. From the data obtained, it can be assumed that changes in the concentrations of various tryptophan metabolites have a relationship with the level of adipokine/myokine secretion and, consequently, with the development of metabolically healthy or metabolically unhealthy obesity.
    Type of Medium: Online Resource
    ISSN: 2224-6452 , 2224-6444
    Uniform Title: МЕТАБОЛИТЫ ТРИПТОФАНА – МЕДИАТОРЫ ОСИ «МИКРОБИОМ КИШЕЧНИКА – ЖИРОВАЯ ТКАНЬ»
    URL: Issue
    Language: Russian
    Publisher: RIOR Publishing Center
    Publication Date: 2022
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...